Sarika: Created page with "{{Testcases notice}} * Merge {{lts|Infobox neurohormone}} into {{lts|Infobox drug}} (2017) * Add gene therapy section (2018) This testcase page uses {{tl|Infobox drug/sandbox..."

2022-05-23T05:08:55Z

Created page with "{{Testcases notice}} * Merge {{lts|Infobox neurohormone}} into {{lts|Infobox drug}} (2017) * Add gene therapy section (2018) This testcase page uses {{tl|Infobox drug/sandbox..."

New page

{{Testcases notice}}
* Merge {{lts|Infobox neurohormone}} into {{lts|Infobox drug}} (2017)
* Add gene therapy section (2018)

This testcase page uses {{tl|Infobox drug/sandbox}}. Diff: {{DiffPages|page1=Template:Infobox drug|page2=Template:Infobox drug/sandbox|listpages=yes}}.

* Testing [[Gene therapy]]{{Infobox drug/testcases/navbox|state=collapsed}}

* Diff: {{DiffPages|page1=Template:Infobox drug|page2=Template:Infobox drug/sandbox|listpages=yes}}.

;Has (data page)
:[[Template:Infobox drug/testcases11 (data page)]]
:This page has a data page to test this situation. (example: [[Caffeine]] has [[Caffeine (data page)]])

==(data page)==
:Jan 2022: {{para|data page}}
: This testpage has DP: [[:Template:Infobox drug/testcases11 (data page)]]
:(new) {{tl|Infobox drug/data page link}}

* {{para|data page}} absent (dflt)
{{testcase table
|pronounce = test (DP) -dflt
}}

* {{para|data page|<blank>}}
{{testcase table
|pronounce = test (DP) -dp=blank
|data page=
}}

:{{para|data page|Water (data page)}}
{{testcase table
|pronounce = test (DP) -dp=water(DP)
|data page=Water (data page)
}}

:{{para|data page|<nowiki>[[Water (data page)]]</nowiki>}}
{{testcase table
|pronounce = test (DP) -dp=[water(DP)]
|data page=[[Water (data page)]]
}}

:{{para|data page|none}}
{{testcase table
|pronounce = test (DP) -dp=none
|data page=none
}}

==other older==
:{{para|data page|[[Water (data page)]]}}
{{testcase table
|name = test (data page)
|data_page = [[Water (data page)]]
| Verifiedfields = changed
| verifiedrevid = 415028406

}}

:{{para|dat_ page|Foobar (xyz page)}}

{{testcase table
|name = test (data page) 3
|data_page = Foobar (xyz page)
| Verifiedfields = changed
| verifiedrevid = 415028406

}}

==Gene therapy==

* Pilot article is [[Voretigene neparvovec]]
{{testcase table
| type=
| drug name = [[Voretigene neparvovec]]
| gt_target_gene = [[RPE65]]
| gt_vector = [[Adeno-associated virus|adenovirus serotype 2]]
| gt_nucleic_acid_type = [not applicable here]
| gt_editing_method = [not applicable here]
| gt_delivery_method = [not applicable here]
}}

;2
{{testcase table
| type=
| drug name = [[Voretigene neparvovec]]
| gt_target_gene = [[RPE65]]
| gt_vector = [[Adeno-associated virus|adenovirus serotype 2]]
| gt_nucleic_acid_type = [not applicable here]
| gt_editing_method = [not applicable here]
| gt_delivery_method = [not applicable here]
}}

==Testcase 1==
;Testcase comparing the previous template (now deprecated)
{{cot|title=nowiki}}
<nowiki>
{| style="vertical-align:top"
|-
| colspan=2 | [[Oxytocin]]
|-
| {{tl|Infobox drug/sandbox}}
| {{tl|Infobox neurohormone}}
|-
|{{Infobox drug/sandbox
| type=
| drug_name = Oxytocin (hormone)
| IUPAC_name = 1-({(4''R'',7''S'',10''S'',13''S'',16''S'',19''R'')-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1''S'')-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
| image = Oxytocin with labels.png
| width = 250px


| source_tissues = [[posterior pituitary]]
| target_tissues = [[central nervous system]]
| receptors = [[oxytocin receptor]]
| agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]]
| antagonists = [[atosiban]], [[epelsiban]], [[retosiban]]
| precursor = [[Neurophysin I|oxytocin-neurophysin 1]]
| biosynthesis = [[magnolysin]]
| metabolism = [[oxytocinase]]

| legal_US= blabla-test
| class = clinicalclass

| bioavailability =
| protein_bound = 30%


| CAS_number_Ref = {{cascite|correct}}
| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2
| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N
}}

|{{Infobox neurohormone


| name = Oxytocin (hormone)
| alt = 
| IUPACName = 1-({(4''R'',7''S'',10''S'',13''S'',16''S'',19''R'')-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1''S'')-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
| synonyms =
| abbrev = 
| image = Oxytocin with labels.png


| sources = [[posterior pituitary]]
| targets = [[central nervous system]]
| receptors = [[oxytocin receptor]]
| agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]]
| antagonists = [[atosiban]], [[epelsiban]], [[retosiban]]
| precursor = [[Neurophysin I|oxytocin-neurophysin 1]]
| synth = [[magnolysin]]
| breakdown = [[oxytocinase]]


| CAS_number_Ref = {{cascite|correct}}
| CAS_number = 50-56-6


| C=43 | H=66 | N=12 | O=12 | S=2
| molecular_weight = 1007.19 g/mol
| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N

| footnotes =
}}
|}
</nowiki>
{{cob}}

==test metabolism in two sections==
{{tl|Infobox drug/sandbox}}
{{testcase table
| type=
| drug_name = M. with physiological data only
| IUPAC_name =

| source_tissues = [[posterior pituitary]]
| target_tissues = [[central nervous system]]
| receptors = [[oxytocin receptor]]
| agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]]
| antagonists = [[atosiban]], [[epelsiban]], [[retosiban]]
| precursor = [[Neurophysin I|oxytocin-neurophysin 1]]
| biosynthesis = [[magnolysin]]
| metabolism = [[oxytocinase]]


| bioavailability =
| protein_bound = 


| CAS_number_Ref = {{cascite|correct}}
| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2
| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N
}}

{{testcase table
| type=
| drug_name = M. with pharmacokinetic data only
| IUPAC_name =

| metabolism = [[oxytocinase]]


| bioavailability = xyz
| protein_bound = 30%


| CAS_number_Ref = {{cascite|correct}}
| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2
| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N
}}

{{testcase table
| type=
| drug_name = M. with physio and pharmacokin data both
| IUPAC_name =

| source_tissues = [[posterior pituitary]]
| target_tissues = [[central nervous system]]
| receptors = [[oxytocin receptor]]
| agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]]
| antagonists = [[atosiban]], [[epelsiban]], [[retosiban]]
| precursor = [[Neurophysin I|oxytocin-neurophysin 1]]
| biosynthesis = [[magnolysin]]
| metabolism = [[oxytocinase]]


| bioavailability = xyz
| protein_bound = 30%


| CAS_number_Ref = {{cascite|correct}}
| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2
| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N
}}

{{testcase table
| type=
| drug_name = M. with M. value only
| IUPAC_name =

| source_tissues =
| target_tissues =
| receptors =
| agonists =
| antagonists =
| precursor =
| biosynthesis =
| metabolism = [[oxytocinase]]


| bioavailability =
| protein_bound =


| CAS_number_Ref = {{cascite|correct}}
| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2
| molecular_weight = 1007.19 g/mol

}}

==text metabolism, and pronunciation==
{{cot|title=nowiki}}
<nowiki>
{{tl|Infobox drug/sandbox}}
{{testcase table
| type=
| drug_name = M. with physiological data only
| IUPAC_name =
| pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}}
| image = Aspirin-skeletal.svg

| source_tissues = [[posterior pituitary]]
| target_tissues = [[central nervous system]]
| receptors = [[oxytocin receptor]]
| agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]]
| antagonists = [[atosiban]], [[epelsiban]], [[retosiban]]
| precursor = [[Neurophysin I|oxytocin-neurophysin 1]]
| biosynthesis = [[magnolysin]]
| metabolism = [[oxytocinase]]


| bioavailability =
| protein_bound = 


| CAS_number_Ref = {{cascite|correct}}
| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2
| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N
}}

{{testcase table
| type=
| drug_name = M. with pharmacokinetic data only
| IUPAC_name =
| pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}}
| image = Aspirin-skeletal.svg


| metabolism = [[oxytocinase]]


| bioavailability = xyz
| protein_bound = 30%


| CAS_number_Ref = {{cascite|correct}}
| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2
| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N
}}

{{testcase table
| type=
| drug_name = M. with physio and pharmacokin data both
| IUPAC_name =
| pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}}
| image = Aspirin-skeletal.svg


| source_tissues = [[posterior pituitary]]
| target_tissues = [[central nervous system]]
| receptors = [[oxytocin receptor]]
| agonists = [[carbetocin]], [[demoxytocin]], [[merotocin]]
| antagonists = [[atosiban]], [[epelsiban]], [[retosiban]]
| precursor = [[Neurophysin I|oxytocin-neurophysin 1]]
| biosynthesis = [[magnolysin]]
| metabolism = [[oxytocinase]]


| bioavailability = xyz
| protein_bound = 30%


| CAS_number_Ref = {{cascite|correct}}
| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2
| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N
}}

{{testcase table
| type=
| drug_name = M. with M. value only
| IUPAC_name =
| pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}}
| image = Aspirin-skeletal.svg


| source_tissues =
| target_tissues =
| receptors =
| agonists =
| antagonists =
| precursor =
| biosynthesis =
| metabolism = [[oxytocinase]]


| bioavailability =
| protein_bound =


| CAS_number_Ref = {{cascite|correct}}
| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2
| molecular_weight = 1007.19 g/mol

}}
</nowiki>
{{cob}}

Template:Infobox drug/testcases11 - Revision history

Sarika: Created page with "{{Testcases notice}} * Merge {{lts|Infobox neurohormone}} into {{lts|Infobox drug}} (2017) * Add gene therapy section (2018) This testcase page uses {{tl|Infobox drug/sandbox..."